Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e00fe38ef2a641501d249b93afdfd0c9 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-8964 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-8964 |
filingDate |
2009-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d841b4f9da39f020bc0ddf3b72fe8d8 |
publicationDate |
2009-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2721087-A1 |
titleOfInvention |
Anticancer methods using extracts of anemarrhena asphodeloides bunge |
abstract |
Selective apoptotic extracts of Anemarrhena asphodeloides Bunge are provided. Also provided are methods of using said extracts to induce apoptosis in specific cells, especially in a human. Provided as well are uses of the extracts of Anemarrhena asphodeloides Bunge for the preparation of a medicament for the selective induction of apoptosis in a living being. |
priorityDate |
2008-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |